The role of NLRP3 inflammasome-mediated pyroptosis in astrocytes during hyperoxia-induced brain injury
Authors:
- 25 January 2025
- journal article
- review article
- Published by Springer Nature in Inflammation Research
- Vol. 74 (1) , 1-15
Abstract
Background Hyperoxia-induced brain injury is a severe neurological complication that is often accompanied by adverse long-term prognosis. The pathogenesis of hyperoxia-induced brain injury is highly complex, with neuroinflammation playing a crucial role. The activation of the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome, which plays a pivotal role in regulating and amplifying the inflammatory response, is the pathological core of hyperoxia-induced brain injury. Additionally, astrocytes actively participate in neuroinflammatory responses. However, there is currently no comprehensive overview summarizing the role of astrocytes in hyperoxia-induced brain injury and the NLRP3 signaling pathways in astrocytes. Objective This article aims to provide an overview of studies reported in the literature investigating the pathological role of astrocyte involvement during the inflammatory response in hyperoxia-induced brain injury, the mechanisms of hyperoxia activateing the NLRP3 inflammasome to mediate pyroptosis in astrocytes, and the potential therapeutic effects of drugs targeting the NLRP3 inflammasome to alleviate hyperoxia-induced brain injury. Method We searched major databases (including PubMed, Web of Science, and Google Scholar, etc.) for literature encompassing astrocytes, NLRP3 inflammasome, and pyroptosis during hyperoxia-induced brain injury up to Oct 2024. We combined with studies found in the reference lists of the included studies. Conclusion In this study, we elucidated the transition of function in astrocytes and activation mechanisms under hyperoxic conditions, and we summarized the potential upstream of the trigger involved in NLRP3 inflammasome activation during hyperoxia-induced brain injury, such as ROS and potassium efflux. Furthermore, we described the signaling pathways of the NLRP3 inflammasome and pyroptosis executed by GSDMD and GSDME in astrocytes under hyperoxic conditions. Finally, we summarized the inhibitors targeting the NLRP3 inflammasome in astrocytes to provide new insights for treating hyperoxia-induced brain injury.Keywords
Funding Information
- The National Natural Science Foundation of China (82002397)
This publication has 124 references indexed in Scilit:
- Activation of NLRP3 inflammasome in a rat model of cerebral small vessel diseaseExperimental Brain Research, 2024
- Oxygen and HIF1α‐dependent SDF1 expression in primary astrocytesDevelopmental Neurobiology, 2024
- Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseasesInflammation Research, 2023
- Oxygen toxicity: cellular mechanisms in normobaric hyperoxiaCell Biology and Toxicology, 2022
- Targeting Inflammasomes to Treat Neurological DiseasesAnnals of Neurology, 2021
- Protection of MCC950 against Alzheimer's disease via inhibiting neuronal pyroptosis in SAMP8 miceExperimental Brain Research, 2020
- ATP induces caspase-3/gasdermin E-mediated pyroptosis in NLRP3 pathway-blocked murine macrophagesApoptosis, 2019
- Hyperoxia promotes astrocyte cell death after oxygen and glucose deprivationGlia, 2008
- Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and PharmacologyCellular and Molecular Neurobiology, 2005
- Influence of systemic factors on experimental epileptic brain injuryActa Neuropathologica, 1983